bpc-157 mechanism of action tissue healing Peptide Therapy for Inflammation: A New Solution What no one's telling you

The Potential of Retatrutide Retatrutide leads to 24.2% mean WL at the highest dose after 48 weeks in people with obesity, with no evidence of plateau and up to 26% of participants achieving 30% WL - approaching the efficacy Roux-en-y gastric bypass, one of the most effective BS procedures

This route offers easier execution, reduced discomfort, and adequate systemic distribution for most applications

A longer half-life is a pharmacokinetic property, not evidence of a better or safer outcome

At Better Med Spa in Lincoln Park, we see Synapse fitting into several patient profiles: Brain fog and cognitive fatigue

SS-31 (Elamipretide): The First FDA-Approved Mitochondrial Therapeutic In September 2025, the FDA granted accelerated approval to Forzinity (elamipretide), marking a watershed moment in mitochondrial medicine